Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Advantage Solutions A | ADV | 24. dec 2024 | 3.05 | +2.01 |
Advent | AVK | 24. dec 2024 | 11.95 | +1.62 |
Advent Technologies A | ADN | 24. dec 2024 | 5.02 | +14.35 |
Adverum Biotechnologies | ADVM | 24. dec 2024 | 4.74 | 0.00 |
AdvisorShares Pure US Cannabis ETF | MSOS | 24. dec 2024 | 3.68 | +0.55 |
Advisorshares Star Global Buy-Write ETF | VEGA | 24. dec 2024 | 43.74 | +0.43 |
AECOM | ACM | 24. dec 2024 | 108.41 | +0.45 |
Aegon N.V ADR | AEG | 24. dec 2024 | 5.84 | +0.17 |
Aehr Test Systems | AEHR | 24. dec 2024 | 15.13 | +7.69 |
Aemetis | AMTX | 24. dec 2024 | 2.63 | +1.54 |
Aeon Biopharma | AEON | 24. dec 2024 | 0.58 | -2.92 |
AerCap Holdings | AER | 24. dec 2024 | 95.67 | +0.65 |
Aeries Technology | AERT | 24. dec 2024 | 0.88 | +14.16 |
Aerospace & Defense Powershares | PPA | 24. dec 2024 | 116.86 | +0.75 |
Aerovate Therapeutics | AVTE | 24. dec 2024 | 2.60 | +1.56 |
AeroVironment | AVAV | 24. dec 2024 | 160.12 | -0.67 |
AerSale | ASLE | 24. dec 2024 | 6.30 | +2.77 |
AES | AES | 24. dec 2024 | 13.02 | -0.31 |
Aetherium Acquisition A | GMFI | 24. dec 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | 24. dec 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | 24. dec 2024 | 0.57 | +2.88 |
Aeva Technologies | AEVA | 24. dec 2024 | 4.49 | +2.98 |
AEye A | LIDR | 24. dec 2024 | 1.13 | 0.00 |
Affiliated Managers Group | AMG | 24. dec 2024 | 187.49 | +1.54 |
Affimed N.V. | AFMD | 24. dec 2024 | 1.24 | +4.20 |
Affinity Bancshares | AFBI | 24. dec 2024 | 21.86 | -0.41 |
Affirm A | AFRM | 24. dec 2024 | 65.90 | +1.46 |
Aflac | AFL | 24. dec 2024 | 103.24 | +0.49 |
Africa Index ETF Market Vectors | AFK | 24. dec 2024 | 15.68 | -1.01 |
Afya A | AFYA | 24. dec 2024 | 15.57 | +0.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.